ELVAF
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
Jun 3 closing price
Capitalization
9.58M
GLABF
Price
$0.37
Change
+$0.01 (+2.78%)
Updated
Aug 20 closing price
Capitalization
27.22M
Interact to see
Advertisement

ELVAF vs GLABF

Header iconELVAF vs GLABF Comparison
Open Charts ELVAF vs GLABFBanner chart's image
EVONEXT HLDGS SA
Price$0.90
Change-$0.00 (-0.00%)
Volume$400
Capitalization9.58M
GEMINA LABORATORIES
Price$0.37
Change+$0.01 (+2.78%)
Volume$200
Capitalization27.22M
ELVAF vs GLABF Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVAF vs. GLABF commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVAF is a Hold and GLABF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (ELVAF: $0.90 vs. GLABF: $0.37)
Brand notoriety: ELVAF and GLABF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVAF: 100% vs. GLABF: 2%
Market capitalization -- ELVAF: $9.58M vs. GLABF: $27.22M
ELVAF [@Biotechnology] is valued at $9.58M. GLABF’s [@Biotechnology] market capitalization is $27.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVAF’s FA Score shows that 1 FA rating(s) are green whileGLABF’s FA Score has 0 green FA rating(s).

  • ELVAF’s FA Score: 1 green, 4 red.
  • GLABF’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVAF is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 5 TA indicator(s) are bullish.

  • GLABF’s TA Score: 5 bullish, 3 bearish.

Price Growth

ELVAF (@Biotechnology) experienced а 0.00% price change this week, while GLABF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.59%, and the average quarterly price growth was +30.71%.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLABF($27.2M) has a higher market cap than ELVAF($9.58M). ELVAF YTD gains are higher at: 0.000 vs. GLABF (-32.530). ELVAF has higher annual earnings (EBITDA): 1.05M vs. GLABF (-3.73M). ELVAF has more cash in the bank: 6.75M vs. GLABF (15K). GLABF has higher revenues than ELVAF: GLABF (10.9K) vs ELVAF (0).
ELVAFGLABFELVAF / GLABF
Capitalization9.58M27.2M35%
EBITDA1.05M-3.73M-28%
Gain YTD0.000-32.530-
P/E Ratio5.19N/A-
Revenue010.9K-
Total Cash6.75M15K45,020%
Total DebtN/A244K-
FUNDAMENTALS RATINGS
ELVAF: Fundamental Ratings
ELVAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVAFGLABF
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
58%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
52%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
48%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
37%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
31%
Bullish Trend 4 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
28%
Bearish Trend 4 days ago
52%
Advances
ODDS (%)
N/A
Bullish Trend 27 days ago
83%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
50%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TREP0.03N/A
+4.31%
Afinida, Inc.
SONVF285.000.99
+0.35%
Sonova Holding AG
CSCMY0.51N/A
N/A
COSCO Shipping International (Singapore) Co., Ltd.
QNTQF6.50N/A
N/A
Qinetiq Group Plc.
MBGPF0.85N/A
N/A
MOBERG PHARMA AB

ELVAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVAF has been closely correlated with WHWK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if ELVAF jumps, then WHWK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVAF
1D Price
Change %
ELVAF100%
N/A
WHWK - ELVAF
76%
Closely correlated
+1.98%
CLYYF - ELVAF
47%
Loosely correlated
N/A
GLABF - ELVAF
34%
Loosely correlated
N/A
SIGY - ELVAF
31%
Poorly correlated
+40.98%
WXXWY - ELVAF
31%
Poorly correlated
+8.25%
More

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
33%
Loosely correlated
N/A
VANI - GLABF
29%
Poorly correlated
-2.54%
WHWK - GLABF
23%
Poorly correlated
+1.98%
VKTX - GLABF
20%
Poorly correlated
-1.92%
ENTO - GLABF
8%
Poorly correlated
+5.81%
More